Homepage

Sandoz HACk - Healthcare Access Challenge

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW
Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Biosimilars in the US: Time to stop the towels blocking the deckchairs
Featured / Aug 28

Biosimilars in the US: Time to stop the towels blocking the deckchairs

Richard Saynor via LinkedIn

Learn More
View All
Media Release / Nov 12

Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment

Read More
Media Release / Nov 11

Sandoz announces agreement to acquire Aspen’s Japanese operations and associated assets, strengthening position in world’s third largest generics market

Read More
Media Release / Nov 05

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar ZiextenzoTM (pegfilgrastim-bmez)

Read More
Media Release / Oct 22

Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US

Read More
View All
Inflammatory Bowel Disease (IBD) is a chronic illness that affects patients for the rest of their lives. Living wit… https://t.co/DShJy5p667 1 day 19 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More